A multi-center retrospective study to determine effects of immunization to SARS-CoV-2 vaccination in allogeneic transplanted patients
Latest Information Update: 17 Jan 2023
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 17 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition